Literature DB >> 10900537

Monoolein: a review of the pharmaceutical applications.

A Ganem-Quintanar1, D Quintanar-Guerrero, P Buri.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10900537     DOI: 10.1081/ddc-100101304

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


× No keyword cloud information.
  22 in total

1.  Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A.

Authors:  Luciana B Lopes; Denise A Ferreira; Daniel de Paula; M Tereza J Garcia; José A Thomazini; Márcia C A Fantini; M Vitória L B Bentley
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

2.  Feedback Regulation between Aquatic Microorganisms and the Bloom-Forming Cyanobacterium Microcystis aeruginosa.

Authors:  Meng Zhang; Tao Lu; Hans W Paerl; Yiling Chen; Zhenyan Zhang; Zhigao Zhou; Haifeng Qian
Journal:  Appl Environ Microbiol       Date:  2019-10-16       Impact factor: 4.792

3.  Liquid crystalline systems for transdermal delivery of celecoxib: in vitro drug release and skin permeation studies.

Authors:  Eder André Estracanholli; Fabíola Silva Garcia Praça; Ana Beatriz Cintra; Maria Bernadete Riemma Pierre; Marilisa Guimarães Lara
Journal:  AAPS PharmSciTech       Date:  2014-07-01       Impact factor: 3.246

4.  Counter ions and constituents combination affect DODAX : MO nanocarriers toxicity in vitro and in vivo.

Authors:  Ana Cristina Norberto Oliveira; Marisa Passos Sárria; Pedro Moreira; Joana Fernandes; Lisandra Castro; Ivo Lopes; Manuela Côrte-Real; Artur Cavaco-Paulo; Maria Elisabete Cunha Dias Real Oliveira; Andreia Castro Gomes
Journal:  Toxicol Res (Camb)       Date:  2016-06-13       Impact factor: 3.524

5.  Binary blend of glyceryl monooleate and glyceryl monostearate for magnetically induced thermo-responsive local drug delivery system.

Authors:  Abebe E Mengesha; Robert J Wydra; J Zach Hilt; Paul M Bummer
Journal:  Pharm Res       Date:  2013-10-25       Impact factor: 4.200

6.  Absorption mechanism of DHP107, an oral paclitaxel formulation that forms a hydrated lipidic sponge phase.

Authors:  Yura Jang; Hye Jin Chung; Jung Wan Hong; Cheol-Won Yun; Hesson Chung
Journal:  Acta Pharmacol Sin       Date:  2016-11-21       Impact factor: 6.150

7.  A Lipid-Based In Situ-Forming Hexagonal Phase for Prolonged Retention and Drug Release in the Breast Tissue.

Authors:  Giovanna C Salata; Isabella D Malagó; Luciana B Lopes
Journal:  AAPS PharmSciTech       Date:  2022-09-19       Impact factor: 4.026

8.  Multifunctional nanoparticles for prostate cancer therapy.

Authors:  Shantanu S Chandratre; Alekha K Dash
Journal:  AAPS PharmSciTech       Date:  2014-09-05       Impact factor: 3.246

9.  Lamellar liquid crystalline phases for cutaneous delivery of Paclitaxel: impact of the monoglyceride.

Authors:  Jaclyn M Hosmer; Alexandre A Steiner; Luciana B Lopes
Journal:  Pharm Res       Date:  2012-11-08       Impact factor: 4.200

10.  Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies.

Authors:  Salwa Salah; Azza A Mahmoud; Amany O Kamel
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.